The alarmingly high smoking rate in people living with hepatitis C is likely to be offsetting any gains made through treatment with direct-acting antivirals, public health experts warn. Writing in the Lancet, the Australian researchers say early research findings suggest that hepatitis C (HCV), like HIV, increases susceptibility to tobacco-related diseases. And it is estimated that ...
Smoking may undermine gains made through DAA treatment, experts warn
By Tessa Hoffman
9 Nov 2017